| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-065643 |
| cik | 1807120 |
| name | DESIGN THERAPEUTICS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | CA |
| cityba | CARLSBAD |
| zipba | 92011 |
| bas1 | 6005 HIDDEN VALLEY ROAD |
| bas2 | SUITE 110 |
| baph | 858-293-4900 |
| countryma | US |
| stprma | CA |
| cityma | CARLSBAD |
| zipma | 92011 |
| mas1 | 6005 HIDDEN VALLEY ROAD |
| mas2 | SUITE 110 |
| countryinc | US |
| stprinc | DE |
| ein | 823929248 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250507 |
| accepted | 2025-05-07 16:07:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | dsgn-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-065643 | 20241231 | Additional Paid In Capital Common Stock | 468830000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Accounts Payable Current | 2186000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Accrued Expenses And Other Current Liabilities Related Parties Current | 821000.0000 | USD | 0 | 0000950170-25-065643 | |||
| 0000950170-25-065643 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 8197000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-065643 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 411000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1407000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Liabilities And Stockholders Equity | 252093000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Net Income Loss | -17715000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Operating Costs And Expenses | 228000.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0000950170-25-065643 | 20250331 | Operating Income Loss | -20418000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Payments To Acquire Property Plant And Equipment | 72000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Prepaid Expense And Other Assets Current | 3970000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Proceeds From Stock Options Exercised | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Selling General And Administrative Expense | 134000.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0000950170-25-065643 | 20240331 | Share Based Compensation | 3184000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-065643 | 20250331 | Stockholders Equity | -244929000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20241231 | Property Plant And Equipment Net | 1410000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Accounts Payable And Other Accrued Liabilities Current | 6276000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Accounts Payable And Other Accrued Liabilities Current | 5056000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 1731000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Accrued Expenses And Other Current Liabilities Related Parties Current | 800000.0000 | USD | 0 | 0000950170-25-065643 | |||
| 0000950170-25-065643 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3184000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3184000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20250331 | Assets | 237475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Earnings Per Share Diluted | -0.3100 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Liabilities Current | 8236000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Income Loss | -11105000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-065643 | 20250331 | Operating Expenses | 20418000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Other Assets | 427000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 66470000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 94490000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Research And Development Expense | 9801000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Research And Development Expense | 213000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Lease Agreements; | ||
| 0000950170-25-065643 | 20250331 | Retained Earnings Accumulated Deficit | -244929000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Shares Outstanding | 56754341.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20231231 | Stockholders Equity | 455245000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20240331 | Stockholders Equity | -188731000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20241231 | Stockholders Equity | 468830000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 14337.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20250331 | Additional Paid In Capital Common Stock | 472392000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3539000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3539000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20250331 | Cash And Cash Equivalents At Carrying Value | 13667000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Comprehensive Income Net Of Tax | -17740000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Depreciation | 159000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | General And Administrative Expense | 75000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Lease Agreements; | ||
| 0000950170-25-065643 | 20240331 | General And Administrative Expense | 60000.0000 | USD | 1 | us-gaap/2024 | Related Party Transaction= Consulting Agreements; Related Party Transactions By Related Party= Marlinspike Group L L C; | ||
| 0000950170-25-065643 | 20250331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -301000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Cash Provided By Used In Financing Activities | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Net Cash Provided By Used In Operating Activities | -16789000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Income Loss | -11105000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20250331 | Net Income Loss | -17715000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20240331 | Operating Costs And Expenses | 224000.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0000950170-25-065643 | 20241231 | Operating Lease Liability Noncurrent | 1534000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Shares Outstanding | 56768678.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20240331 | Stockholders Equity | 458449000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 56757827.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 450000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Comprehensive Income Net Of Tax | -11334000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Earnings Per Share Basic | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | General And Administrative Expense | 5041000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Cash Provided By Used In Investing Activities | 20616000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Cash Provided By Used In Operating Activities | -12439000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Net Income Loss | -17715000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-065643 | 20240331 | Operating Expenses | 14400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Operating Income Loss | -14400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -229000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20250331 | Payments To Acquire Investments | 86548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Share Based Compensation | 3184000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Stockholders Equity | 242097000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Stockholders Equity | 475000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20250331 | Stockholders Equity | 472392000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20250331 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 20673.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 56757827.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Payments To Acquire Property Plant And Equipment | 195000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Operating Lease Right Of Use Asset | 2027000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -229000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 1060000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Cash And Cash Equivalents At Carrying Value | 22563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -8896000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Common Stock Shares Issued | 56754341.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Common Stock Shares Issued | 56768678.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Common Stock Shares Outstanding | 56754341.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Common Stock Shares Outstanding | 56768678.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Earnings Per Share Diluted | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -2523000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Investment Income Interest | 3295000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Marketable Securities Current | 222914000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Non Cash Lease Expense Income | 4000.0000 | USD | 1 | 0000950170-25-065643 | |||
| 0000950170-25-065643 | 20241231 | Operating Lease Right Of Use Asset | 2216000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Prepaid Expense And Other Assets Current | 2563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Profit Loss | -17715000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Research And Development Expense | 15377000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Research And Development Expense | 11000.0000 | USD | 1 | us-gaap/2024 | Related Party Transaction= Research Consulting Agreements; | ||
| 0000950170-25-065643 | 20250331 | Share Based Compensation | 3539000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-065643 | 20231231 | Stockholders Equity | 277687000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Stockholders Equity | -227214000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 56488527.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Assets | 252093000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Assets Current | 248040000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 54000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 21200000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13667000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-065643 | 20240331 | Depreciation | 143000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Investment Income Interest | 2703000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Liabilities And Stockholders Equity | 237475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Marketable Securities Current | 216007000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Net Income Loss | -11105000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -25000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20240331 | Payments To Acquire Investments | 45659000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Profit Loss | -11105000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Property Plant And Equipment Net | 1377000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20231231 | Stockholders Equity | 62000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20240331 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 14337.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 20000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 29397000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 22563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Earnings Per Share Basic | -0.3100 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | General And Administrative Expense | 74000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Lease Agreements; | ||
| 0000950170-25-065643 | 20241231 | Liabilities | 9996000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Liabilities | 9556000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Net Cash Provided By Used In Financing Activities | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Operating Lease Liability Noncurrent | 1320000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Other Assets | 427000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Proceeds From Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Research And Development Expense | 11000.0000 | USD | 1 | us-gaap/2024 | Related Party Transaction= Research Consulting Agreements; | ||
| 0000950170-25-065643 | 20250331 | Share Based Compensation | 3539000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20231231 | Shares Outstanding | 56473598.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20240331 | Shares Outstanding | 56494271.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20231231 | Stockholders Equity | -177626000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065643 | 20250331 | Stockholders Equity | 227919000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Stockholders Equity | 450000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065643 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 56488527.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | General And Administrative Expense | 4599000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Accounts Payable Current | 3180000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Assets Current | 233644000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | General And Administrative Expense | 60000.0000 | USD | 1 | us-gaap/2024 | Related Party Transaction= Consulting Agreements; Related Party Transactions By Related Party= Marlinspike Group L L C; | ||
| 0000950170-25-065643 | 20241231 | Liabilities Current | 8462000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Net Cash Provided By Used In Investing Activities | 7870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20250331 | Non Cash Lease Expense Income | -4000.0000 | USD | 1 | 0000950170-25-065643 | |||
| 0000950170-25-065643 | 20250331 | Research And Development Expense | 217000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Lease Agreements; | ||
| 0000950170-25-065643 | 20241231 | Retained Earnings Accumulated Deficit | -227214000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Selling General And Administrative Expense | 135000.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0000950170-25-065643 | 20231231 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065643 | 20240331 | Stockholders Equity | 269557000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065643 | 20240331 | Stockholders Equity | -167000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065643 | 20241231 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Non Cash Lease Expense Income | 0000950170-25-065643 | 1 | 0 | monetary | D | D | Non Cash Lease Expense Income | Non-cash lease expense (income). |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Payments To Acquire Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale | Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Accrued Expenses And Other Current Liabilities Related Parties Current | 0000950170-25-065643 | 1 | 0 | monetary | I | C | Accrued expenses and other current liabilities Related Parties, Current | Accrued expenses and other current liabilities Related Parties, Current |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets | Amount of assets classified as other. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-065643 | 4 | 9 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0000950170-25-065643 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-065643 | 2 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Investment securities | 0 |
| 0000950170-25-065643 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-065643 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-065643 | 2 | 7 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-065643 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use asset, related party | 0 |
| 0000950170-25-065643 | 2 | 9 | BS | 0 | H | Other Assets | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-065643 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-065643 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-065643 | 2 | 14 | BS | 0 | H | Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities (including related party amounts of $821 and $800 respectively) | 0 |
| 0000950170-25-065643 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-065643 | 2 | 16 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net, related party | 0 |
| 0000950170-25-065643 | 2 | 17 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-065643 | 2 | 18 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (See Note 8) | 0 |
| 0000950170-25-065643 | 2 | 20 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2025 and December 31, 2024; 56,768,678 and 56,754,341 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-065643 | 2 | 21 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-065643 | 2 | 22 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-065643 | 2 | 23 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0000950170-25-065643 | 2 | 24 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-065643 | 2 | 25 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-065643 | 3 | 1 | BS | 1 | H | Accrued Expenses And Other Current Liabilities Related Parties Current | 0000950170-25-065643 | Accrued expenses and other current liabilities, related party amounts | 0 |
| 0000950170-25-065643 | 3 | 2 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-065643 | 3 | 3 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-065643 | 3 | 4 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-065643 | 3 | 5 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-065643 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development (including related party amounts of $228 and $224, respectively) | 0 |
| 0000950170-25-065643 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative (including related party amounts of $134 and $135, respectively) | 0 |
| 0000950170-25-065643 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-065643 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-065643 | 4 | 6 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0000950170-25-065643 | 4 | 7 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-065643 | 4 | 8 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0000950170-25-065643 | 4 | 10 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average shares of common stock outstanding, basic | 0 |
| 0000950170-25-065643 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average shares of common stock outstanding, diluted | 0 |
| 0000950170-25-065643 | 5 | 6 | IS | 1 | H | Operating Costs And Expenses | us-gaap/2024 | Research and development expenses related party amount | 0 |
| 0000950170-25-065643 | 5 | 7 | IS | 1 | H | Selling General And Administrative Expense | us-gaap/2024 | General and administrative expenses related party amount | 0 |
| 0000950170-25-065643 | 6 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-065643 | 6 | 3 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on available-for-sale securities | 0 |
| 0000950170-25-065643 | 6 | 4 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0000950170-25-065643 | 7 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-065643 | 7 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, Shares | 0 |
| 0000950170-25-065643 | 7 | 11 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercises of stock options | 0 |
| 0000950170-25-065643 | 7 | 12 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercises of stock options, Shares | 0 |
| 0000950170-25-065643 | 7 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-065643 | 7 | 15 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on investments | 0 |
| 0000950170-25-065643 | 7 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-065643 | 7 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-065643 | 7 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, Shares | 0 |
| 0000950170-25-065643 | 8 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-065643 | 8 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0000950170-25-065643 | 8 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-065643 | 8 | 6 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Amortization of premiums on investment securities, net | 1 |
| 0000950170-25-065643 | 8 | 7 | CF | 0 | H | Non Cash Lease Expense Income | 0000950170-25-065643 | Non-cash lease expense | 0 |
| 0000950170-25-065643 | 8 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expense and other assets | 1 |
| 0000950170-25-065643 | 8 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
| 0000950170-25-065643 | 8 | 11 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-065643 | 8 | 13 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Purchases of investment securities | 1 |
| 0000950170-25-065643 | 8 | 14 | CF | 0 | H | Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | Proceeds from maturities of investment securities | 0 |
| 0000950170-25-065643 | 8 | 15 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-065643 | 8 | 16 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-065643 | 8 | 18 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from the exercise of stock options | 0 |
| 0000950170-25-065643 | 8 | 19 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-065643 | 8 | 20 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash and cash equivalents | 0 |
| 0000950170-25-065643 | 8 | 21 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0000950170-25-065643 | 8 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0000950170-25-065643 | 8 | 24 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Purchases of property and equipment included in accounts payable and accrued expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |